Recent Finacing
Recent Raise
QLIDA develops a point-of-care mobile diagnostic device that uses disposable finger‑prick blood samples to multiplex-detect cardiac biomarkers (troponin, BNP, myeloperoxidase) for triage and near-term risk monitoring.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors